Head and Neck Pathology

, Volume 6, Supplement 1, pp 98–103

The Role for Surgical Management of HPV-Related Oropharyngeal Carcinoma

Invited Review


Human papillomavirus (HPV)-associated oropharyngeal carcinoma has become the predominate cause of oropharyngeal carcinoma in the United States and Europe. Management of this disease is controversial. Traditional open surgical techniques gave way to concurrent chemoradiotherapy following several American and European organ-preservation trials suggesting that both modalities were equally efficacious. More recently, minimally invasive surgical techniques have gained popularity. These techniques provide an opportunity to achieve a complete surgical resection without the treatment-related morbidity associated with open surgery. Proponents of this technique contend that transoral surgical techniques provide a means to analyze the tumor tissue, prognosticate, and personally direct therapy. Skeptics suggest that HPV-associated oropharyngeal carcinoma responds well to chemoradiotherapy and that surgery may not provide a treatment advantage. Both approaches provide a unique perspective and both are currently being studied under trial.


Human papillomavirus Robot Surgery Minimally invasive 


  1. 1.
    Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:612–9.CrossRefGoogle Scholar
  2. 2.
    Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer. 2008;113:2901–9.PubMedCrossRefGoogle Scholar
  3. 3.
    zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res. 1976;36:794.PubMedGoogle Scholar
  4. 4.
    Moscicki AB. Impact of HPV infection in adolescent populations. J Adolesc Health Off Publ Soc Adolesc Med. 2005;37:S3–9.CrossRefGoogle Scholar
  5. 5.
    Zur Hausen H. Human papilloma viruses and their possible role in squamous cell carcinoma. Curr Top MicrobiolImmunol. 1977;78:1–30.CrossRefGoogle Scholar
  6. 6.
    Newell GR, Krementz ET, Roberts JD. Excess occurrence of cancer of the oral cavity, lung, and bladder following cancer of the cervix. Cancer. 1975;36:2155–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Syrjanen KJ, Syrjanen SM, Lamberg MA, Pyrhonen S. Human papillomavirus (HPV) involvement in squamous cell lesions of the oral cavity. Proc Finn Dent Soc. 1983;79:1–8.PubMedGoogle Scholar
  8. 8.
    Loning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol. 1985;84:417–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A. Molecular classification identifies a subset of human papillomavirus—associated oropharyngeal cancers with favorable prognosis. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:736–47.CrossRefGoogle Scholar
  10. 10.
    Psyrri A, DiMaio D. Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol. 2008;5:24–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Gillison ML, D’Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.PubMedCrossRefGoogle Scholar
  13. 13.
    Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Canc Netw. 2011;9:665–73.PubMedGoogle Scholar
  14. 14.
    Holsinger FC, McWhorter AJ, Menard M, Garcia D, Laccourreye O. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg. 2005;131:583–91.PubMedCrossRefGoogle Scholar
  15. 15.
    Steiner W, Ambrosh P. Endoscopic laser surgery of the upper aerodigestive tract with special emphasis on cancer surgery. New York: Georg Thieme verlag; 2000.Google Scholar
  16. 16.
    Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A, Christiansen H, Haughey BH, Nussenbaum B, Steiner W. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007;133:1198–204.PubMedCrossRefGoogle Scholar
  17. 17.
    Rich JT, Milov S, Lewis JS Jr, Thorstad WL, Adkins DR, Haughey BH. Transoral laser microsurgery (TLM) ± adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope. 2009;119:1709–19.PubMedCrossRefGoogle Scholar
  18. 18.
    Haughey BH, Hinni ML, Salassa JR, Hayden RE, Grant DG, Rich JT, Milov S, Lewis JS Jr, Krishna M. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011;33:1683–94.PubMedCrossRefGoogle Scholar
  19. 19.
    Weinstein GS, O’Malley BW Jr, Snyder W, Sherman E, Quon H. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg. 2007;133:1220–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Hillel AT, Kapoor A, Simaan N, Taylor RH, Flint P: Applications of robotics for laryngeal surgery, Otolaryngol Clin North Am 2008, 41:781–791, vii.Google Scholar
  21. 21.
    Genden EM, Desai S, Sung CK. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck. 2009;31:283–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Genden EM, Park R, Smith C, Kotz T. The role of reconstruction for transoral robotic pharyngectomy and concomitant neck dissection. Arch Otolaryngol Head Neck Surg. 2011;137:151–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope. 2009;119:2156–64.PubMedCrossRefGoogle Scholar
  24. 24.
    Weinstein GS, O’Malley BW Jr, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136:1079–85.CrossRefGoogle Scholar
  25. 25.
    Genden EM, Kotz T, Tong CC, Smith C, Sikora AG, Teng MS, Packer SH, Lawson WL, Kao J. Transoral robotic resection and reconstruction for head and neck cancer. Laryngoscope. 2011;121:1668–74.PubMedCrossRefGoogle Scholar
  26. 26.
    Cohen MA, Weinstein GS, O’Malley BW Jr, Feldman M, Quon H. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck. 2011;33:573–80.PubMedCrossRefGoogle Scholar
  27. 27.
    White HN, Moore EJ, Rosenthal EL, Carroll WR, Olsen KD, Desmond RA, Magnuson JS. Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: 1- and 2-year survival analysis. Arch Otolaryngol Head Neck Surg. 2010;136:1248–52.PubMedCrossRefGoogle Scholar
  28. 28.
    Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:3582–9.CrossRefGoogle Scholar
  29. 29.
    Rich JT, Liu J, Haughey BH. Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer. Laryngoscope. 2011;121:2381–90.PubMedCrossRefGoogle Scholar
  30. 30.
    Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR. The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck. 2004;26:660–74.PubMedCrossRefGoogle Scholar
  31. 31.
    Iseli TA, Kulbersh BD, Iseli CE, Carroll WR, Rosenthal EL, Magnuson JS. Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg. 2009;141:166–71.PubMedCrossRefGoogle Scholar
  32. 32.
    Hurtuk A, Agrawal A, Old M, Teknos TN, Ozer E. Outcomes of transoral robotic surgery: a preliminary clinical experience. Otolaryngol Head Neck Surg. 2011;145:248–53.PubMedCrossRefGoogle Scholar
  33. 33.
    Leonhardt FD, Quon H, Abrahao M, O’Malley BW Jr, Weinstein GS. Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck. 2012;34:146–54.PubMedCrossRefGoogle Scholar
  34. 34.
    Mucksavage P, Kerbl DC, Lee JY. The da Vinci((R)) Surgical System overcomes innate hand dominance. J Endourol. 2011;25:1385–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Chandra V, Nehra D, Parent R, Woo R, Reyes R, Hernandez-Boussard T, Dutta S. A comparison of laparoscopic and robotic assisted suturing performance by experts and novices. Surgery. 2010;147:830–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Hagen ME, Meehan JJ, Inan I, Morel P. Visual clues act as a substitute for haptic feedback in robotic surgery. Surg Endosc. 2008;22:1505–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.The Department of Otolaryngology-Head and Neck SurgeryThe Mount Sinai School of MedicineNew YorkUSA
  2. 2.Head and Neck Cancer CenterThe Mount Sinai Medical CenterNew YorkUSA

Personalised recommendations